N-(2,4-二叔丁基-5-羟基苯基)-4-氧代-1,4... N-(2,4-Di-tert-butyl-5-hydro... 5g

CAS号：873054-44-5

品名：N-(2,4-二叔丁基-5-羟基苯基)-1,4-二氢-4-氧代-3-喹啉甲酰胺ivacaftor

中文别名：N-(2,4-二叔丁基-5-羟基苯基)-1,4-二氢-4-氧代-3-喹啉甲酰胺

英文别名：UNII-1Y740ILL1Z;VX770,VX770,Ivacaftor;N-[2,4-Bis(tert-butyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxo-3-quinolinecarboxamide;N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide;Ivacaftor;N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide;[14C]-Ivacaftor;N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxaraide;Ivacaftor(VX-770);N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide;Kalydeco;VX770;

分子式：C24H28N2O3

分子量：392.491

精确质量：392.21

Psa：85.68

MDL号：MFCD17171361

密度：1.187 g/cm3

沸点：550.4ºC at 760 mmHg

闪点：286.7ºC

简介：Ivacaftor(tradenameKalydeco,developedasVX-770)isadrugusedtotreatcysticfibrosisinpeoplewithcertainmutationsinthecysticfibrosistransmembraneconductanceregulator(CFTR)gene,whoaccountfor4–5%casesofcysticfibrosis,andisincludedinacombinationdrug,lumacaftor/ivacaftor,whichisusedtotreatpeoplewithcysticfibrosiswhohavetheF508delmutationinCFTR.